NCT01223872

Brief Summary

This two-part research study will compare childhood cancer survivors receiving specialized follow-up care in the REACH for Survivorship clinic to patients receiving routine follow-up care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
188

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Aug 2010

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2010

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

October 15, 2010

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 19, 2010

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2015

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2015

Completed
Last Updated

April 4, 2017

Status Verified

March 1, 2017

Enrollment Period

4.8 years

First QC Date

October 15, 2010

Last Update Submit

March 30, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Knowledge gained by attending a multispecialty Survivorship Clinic which will be measured by comparison of self report with medical record data in both cross-sectional and longitudinal approach.

    In addition to data from patient interviews, a review of medical records will include general patient demographic data as well as data regarding cancer diagnosis, treatment and ongoing follow-up care.

    12 months

Secondary Outcomes (3)

  • Characterizing how the initial consultation in a specialized clinic impacts childhood cancer survivors' knowledge of their cancer diagnosis, treatment, and risk of late effects by comparing patient's understanding among 3 sampled timepoints.

    pre-clinic and a post-clinic interviews at 1 and 3 months.

  • An analysis of differences in relative levels of recommended screening for late effects that childhood cancer survivors have received based on the type of their long-term follow-up care comparing medical records against Survivorship Care Plan.

    12 months

  • A qualitative evaluation of program feedback will serve to improve the care provided in the REACH for Survivorship clinic

    12 months

Study Arms (3)

Routine Patient Care

Other: interview

Previously-enrolled REACH Clinic Patients

Other: clinic visit and interview

New REACH Clinic Patients

Other: interviews and clinic visit

Interventions

* Standard Interview (2-15 years from last treatment) * Demographic data interview (pre-initial study interview)

Routine Patient Care

* REACH Clinic Visit(initial or regular) * Post-REACH Clinic Interview (3mos from initial or regular clinic visit) * Demographic data interview(pre-initial study interview)

Previously-enrolled REACH Clinic Patients

* Pre-REACH Clinic Interview(2-15 yrs from last treatment) * REACH Clinic Visit(initial or regular) * Post-REACH Clinic Interview(1mo from initial clinic visit) * Post-REACH Clinic Interview(3mos from initial or regular clinic visit) * Demographic data interview(pre-initial study interview)

New REACH Clinic Patients

Eligibility Criteria

AgeUp to 21 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Fifty new cancer patients in the REACH for Survivorship clinic, fifty returning cancer patients in the REACH for Survivorship clinic, and one hundred routine care cancer patients are expected to enroll in this study.

You may qualify if:

  • Treatment for primary malignancy per risk-adapted protocol
  • Age ≤ 21 years at time of diagnosis
  • Currently alive without evidence of disease
  • Off therapy for no more than 15 years

You may not qualify if:

  • Patients who have received a bone marrow transplant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vanderbilt-Ingram Cancer Center

Nashville, Tennessee, 37232, United States

Location

MeSH Terms

Conditions

Neoplasms

Interventions

Interviews as TopicAmbulatory Care

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public HealthPatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 15, 2010

First Posted

October 19, 2010

Study Start

August 1, 2010

Primary Completion

June 1, 2015

Study Completion

August 1, 2015

Last Updated

April 4, 2017

Record last verified: 2017-03

Locations